Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
This is a controlled, randomized, multi-center prospective study of vardenafil to determine
efficacy on Erectile Dysfunction (ED), tolerability and safety in men with ED and Metabolic
Syndrome. This study will explore the rate of patients who do need to switch to the highest
dosage based upon the expectation that most men can stay on vardenafil 10 mg PRN (pro re
nata)